510(k) · Cleared
ClearedMedicinal Leeches
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
North America BioPharma · NRN Leeches, Medicinal
Cleared on Feb 19, 2014 as substantially equivalent to K040187 (North America BioPharma, 2004) after a 152-day review. Its family tree reaches back 1 generation to 2004. 1 later device descends from it.
- Decided
- Feb 19, 2014
- Review
- 152 days
- Class
- Class U
- Product code
- NRN
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K040187 (2004). 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K140907Leech, MedicinalCarolina Biological Supply Co. · 2015 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K040187 | Medicinal Leeches | North America BioPharma | 2004 | — |
| 0 (this device) | K132958 | Medicinal Leeches | North America BioPharma | 2014 | — |
| +1 | K140907 | Leech, Medicinal | Carolina Biological Supply Co. | 2015 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K040187 | Medicinal LeechesSummary page 2…venous circulation. Leeches can be used to alleviate the problem of venious congestion by creating prolonged localized bleeding. 7. Predicate Device 51 0(k) number: K040187 - Trade name: Medicinal Leeches 8. Summary of the Characteristics of Our Device Compared to Its Predicate Our device and its… | 2004 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K140907 | Leech, Medicinal | 2015 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All NRN devicesNRN Leeches, Medicinal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.
FDA decisions per year · NRN
1in 2015
2026 to Oct 25, outlined.
Median 510(k) review, days · NRN
Too few NRN 510(k)s in any year since 2007 to give a median.
Recalls per year · NRN
No recall names NRN since 2007.
Adverse event reports per year · NRN
5in 2025
MAUDE reports naming product code NRN, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 3 |
| 2013 | 0 | — | 0 | 2 |
| 2014 | 1 | — | 0 | 0 |
| 2015 | 1 | — | 0 | 4 |
| 2016 | 0 | — | 0 | 4 |
| 2017 | 0 | — | 0 | 2 |
| 2018 | 0 | — | 0 | 4 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 4 |
| 2024 | 0 | — | 0 | 5 |
| 2025 | 0 | — | 0 | 5 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Leeches may be used in instances where skin flaps, skin graft, or other tissues are suffering from impaired venous circulation. Leeches may be used to alleviate the problem of venous congestion by creating prolonged localized bleeding.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K132958 · printed Nov 6, 2026
Cite this page
510(k) Report. “K132958: Medicinal Leeches.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K132958
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026